China Literature Limited reported through a Next Day Disclosure Return that 200,000 ordinary shares were repurchased on 7 October 2026 at prices ranging from HKD 19.23 to HKD 19.56, for a total cash outlay of HKD 3.90 million. All repurchased shares are designated for cancellation and none will be held as treasury stock.

Since the share-repurchase programme resumed on 2 September 2026, the company has bought back 5.00 million shares—equivalent to approximately 0.49% of its 1.01 billion issued shares—at an aggregate consideration of about HKD 99.41 million. These shares remain uncancelled as of the latest reporting date.

Despite the ongoing buybacks, the issued share capital stands unchanged at 1,014,293,517 shares because the repurchased shares have not yet been removed from the register.

Under the mandate granted on 2 June 2026, China Literature is authorised to repurchase up to 102.15 million shares. Cumulative repurchases under this mandate now total 18.65 million shares, representing 1.83% of the company’s share count on the mandate date. In accordance with Hong Kong listing rules, the company is restricted from issuing new shares until 6 November 2026.

The company confirmed that all repurchases were executed on the Hong Kong Stock Exchange in compliance with Main Board Rules and that no material changes have been made to the explanatory statement dated 30 April 2026.